title: [Ocular dryness in the side that has been infiltrated and not infiltrated with botulinum toxin to treat hemifacial spasm].
authors.forename: M T
authors.initials: MT
authors.lastname: Pérez-Saldaña
authors.forename: M E
authors.initials: ME
authors.lastname: Boscá-Blasco
authors.forename: J C
authors.initials: JC
authors.lastname: López-Poma
authors.forename: E
authors.initials: E
authors.lastname: España-Gregori
authors.forename: R
authors.initials: R
authors.lastname: Gallego-Pinazo
authors.forename: V
authors.initials: V
authors.lastname: Roda-Marzal
authors.forename: V
authors.initials: V
authors.lastname: Roda-Cámara
authors.forename: J A
authors.initials: JA
authors.lastname: Burguera-Hernández
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001905:Botulinum Toxins / Q000009:adverse effects / Q000627:therapeutic use; D015352:Dry Eye Syndromes / Q000209:etiology*; D005260:Female; D019569:Hemifacial Spasm / Q000188:drug therapy*; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D055815:Young Adult
chemical_list: D001905:Botulinum Toxins